Yongcheng An - Publications

Triple Tumor Microenvironment-Responsive Ferroptosis Pathways Induced by Manganese-Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics.

Journal: Small methods

Published: February 23, 2023

Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: January 04, 2022

GSH-Responsive Metal-Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 13, 2021

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: January 28, 2021

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.

Journal: Biomaterials

Published: September 17, 2020

A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma.

Journal: Biomaterials science

Published: May 21, 2020

Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: February 26, 2020

Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 24, 2019

LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 28, 2019